Gwangju, South Korea

Yong-Chul Kim

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 25(Granted Patents)


Location History:

  • Gwangju, KR (2005 - 2015)
  • Buk-gu Gwangju, KR (2017)

Company Filing History:


Years Active: 2005-2017

Loading Chart...
Loading Chart...
6 patents (USPTO):

Title: Yong-Chul Kim: Innovator in Pharmaceutical Chemistry

Introduction

Yong-Chul Kim is a prominent inventor based in Gwangju, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific receptors involved in neurological pain and cancer treatment. With a total of 6 patents, his work has the potential to impact the medical community significantly.

Latest Patents

Among his latest patents is a novel pyridine carboxylic acid-based compound used as a P2X1 and P2X3 receptor antagonist. This compound serves as a powerful antagonist of these receptors, making it a promising candidate for treating or preventing diseases associated with neurological pain and chronic inflammation. Another notable patent involves pheophorbide-α conjugates, which exhibit fluorescence and inhibit the survival of various cancer cells. This composition is particularly useful in photodynamic therapy (PDT) for cancers, as it combines the effects of a photosensitizer and an anticancer drug.

Career Highlights

Yong-Chul Kim has worked with notable organizations such as Anygen Co., Ltd. and the Gwangju Institute of Science and Technology. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research endeavors.

Collaborations

Some of his coworkers include Jung-Hoon Yoon and Thomas Webb. Their collaborative efforts have contributed to the advancement of innovative solutions in pharmaceutical chemistry.

Conclusion

Yong-Chul Kim's work exemplifies the intersection of innovation and practical application in medicine. His patents reflect a commitment to addressing critical health issues through scientific research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…